| Labcorp

Satya N. Narla, PhD, NRCC(CC)

Dr. Satya Narla is an associate director for the safety testing team at Labcorp Drug Development’s central laboratory. She joined Labcorp in January 2016 as a senior scientist in the immunology department and was promoted to associate director of operations for the safety testing department in 2019.

Sonia Meynier, PhD

Dr. Sonia Meynier joined Labcorp Drug Development in 2021 as a staff scientist in the targeted cell isolation department. In her role, Sonia is responsible for improving and bringing new techniques for cell isolation, defining and analyzing the validations for new procedures, reviewing and providing pricing for new studies and collaborating with the lab to highlight improvements that increase product quality.

Paul Mésange, PhD

Dr. Paul Mésange is the principal scientist of the histology department at Labcorp Central Laboratory Services. Paul completed his PhD in pharmacology in 2014 at Paris Descartes University (France). After two postdoctorates working on preclinical trials at Stanford University (California), he joined a contract research organization in Amsterdam, the Netherlands. Paul joined Labcorp Central Labs in July 2018.

Robert Martone

Robert Martone is a research scientist with deep expertise in neurodegeneration, neuro-oncology, biomarkers and drug discovery. He investigated hereditary neuropathies and the molecular biology of the blood-brain barrier at Columbia University and subsequently managed a portfolio of drug discovery programs at Wyeth Neuroscience targeting Alzheimer’s and Parkinson’s diseases. He was the neuroscience therapeutic area lead for the Labcorp Biomarker Center of Excellence and later established a protein biomarker laboratory at St. Jude Children’s Research Hospital.

LiBin Ma, MD, PhD

Dr. LiBin Ma is a senior medical director in Labcorp’s global medical affairs division. In his current role, LiBin provides medical consultation for Labcorp Central Laboratory Services as well as leadership for global medical affairs division. Prior to this, he was senior director of medical affairs and science for the Asia-Pacific region, responsible for the strategic and operational activities for medical affairs in the region.

Yuhong Li, PhD

Dr. Yuhong Li is a lead scientist in Labcorp’s anatomic pathology and histology (APH) department. In this role, she leads the assay validation team, providing scientific and regulatory support for histology projects and ensuring delivery of high-quality solutions to Labcorp’s customers in Asia. Yuhong is also actively involved in client-facing discussions to describe Labcorp’s APH capabilities.

Yugang Li, MD

Dr. Yugang Li joined anatomic pathology lab and histology services at Labcorp’s central lab in 2022. He brings more than 20 years of experience in diagnostic pathology, including in H&E routine examination, immunohistochemistry and cytopathology. He has previously served as a pathologist at a class A tertiary hospital. In his current role, he provides accurate diagnosis of diseases and histopathologic therapeutic evaluation for clinical trials.

Katherine T. Landschulz, PhD

As therapeutic area lead for the Labcorp Biomarker Solution Center, Dr. Katherine Landschulz has overarching responsibility for the delivery of biomarker strategies for sponsor programs in cardiovascular, metabolic and renal diseases, nonalcoholic fatty liver diseases including NASH, as well as Alzheimer’s, Parkinson’s and other neurodegenerative disease indications.

Alan Lackey

Alan Lackey brings more than 30 years of experience in flow cytometry, having started his career with Cytometry Associates, Inc. in 1989 and following the company’s evolution from Esoterix and Labcorp Clinical Trials to the current Labcorp Drug Development organization. Alan brings significant expertise in assay development, validation and global implementation of assays supporting clinical trials.

Cherub Kim, MD

Dr. Cherub Kim is an anatomic and clinical pathologist with subspecialty training in cytopathology, based at one of Labcorp’s central laboratory sites. Cherub also serves as the medical affairs representative in laboratory informatics, including digital pathology, in his role as clinical informatics lead. In this role, he combines his engineering and computer science backgrounds with his pathology training to support laboratory testing for clinical trials.

Managing Your Health

Diseases & Therapeutic Areas

Treatment Modalities & Methods

Scientific Lab Disciplines

Labs

Industries